Mamoon A. Aldeyab
-
- Antibiotic Use and Resistance 55
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria 15
- Geriatrics and Gerontology top 2%
- Pharmaceutical Practices and Patient Outcomes 19
- Clinical Biochemistry top 1%
- Bacterial Identification and Susceptibility Testing 12
-
- Patient Satisfaction in Healthcare 16
-
- COVID-19 Clinical Research Studies 10
- Antimicrobial Resistance in Staphylococcus 8
-
- Urinary Tract Infections Management 9
- Co-authors
- Michael ScottMary P. KearneyJames C. McElnayFidelma A. MageeFeras Darwish ElhajjiBarbara R. ConwaySayer Al‐AzzamSyed Shahzad Hasan
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)
- Partner nations
- United KingdomJordanUnited Arab Emirates
In The Last Decade
Mamoon A. Aldeyab
75 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 108
- Applied Microbiology and Biotechnology 807
- Molecular Medicine 296
- Geriatrics and Gerontology 176
- Clinical Biochemistry 305
- Critical Care and Intensive Care Medicine 179
Countries citing papers authored by Mamoon A. Aldeyab
This map shows the geographic impact of Mamoon A. Aldeyab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mamoon A. Aldeyab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mamoon A. Aldeyab more than expected).
Fields of papers citing papers by Mamoon A. Aldeyab
This network shows the impact of papers produced by Mamoon A. Aldeyab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mamoon A. Aldeyab. The network helps show where Mamoon A. Aldeyab may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mamoon A. Aldeyab, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 10 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 13 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 3 | |
| 12 | 2023 | 20 | |
| 13 | 2023 | 8 | |
| 14 | 2022 | 25 | |
| 15 | 2022 | 5 | |
| 16 | 2021 | 21 | |
| 17 | 2021 | 11 | |
| 18 | 2021 | 3 | |
| 19 | 2021 | 6 | |
| 20 | 2020 | 3 |
About Mamoon A. Aldeyab
Mamoon A. Aldeyab is a scholar working on Applied Microbiology and Biotechnology, Geriatrics and Gerontology and Molecular Medicine, having authored 83 papers that have together received 1.5k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (55 papers), Pharmaceutical Practices and Patient Outcomes (19 papers), Patient Satisfaction in Healthcare (16 papers), Antibiotic Resistance in Bacteria (15 papers), Bacterial Identification and Susceptibility Testing (12 papers), COVID-19 Clinical Research Studies (10 papers), Urinary Tract Infections Management (9 papers) and Antimicrobial Resistance in Staphylococcus (8 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (807 citations), Molecular Medicine (296 citations) and Geriatrics and Gerontology (176 citations). Mamoon A. Aldeyab has collaborated with scholars based in United Kingdom, Jordan and United Arab Emirates. Frequent co-authors include Michael Scott, Mary P. Kearney, James C. McElnay, Fidelma A. Magee, Feras Darwish Elhajji, Barbara R. Conway, Sayer Al‐Azzam, Syed Shahzad Hasan, Yaser M. Alahmadi and Motasem Aldiab. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.